C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2002
12/31/2002	US6500932 Antihuman thymidylate synthase monoclonal antibodies and hybridomas producing the same
12/31/2002	US6500931 Portion of a complementarity determining region (cdr) derived from a non-human antibody with remaining portions human in origin; use in immunotherapy or as immunotoxins
12/31/2002	US6500929 Protein containing a functional domain of a water-soluble c1 inhibitor and an anchor molecule; suppressing complement activity; membrane bound complement regulatory proteins; transplantation
12/31/2002	US6500928 Mammalian cytokine-like factor 7
12/31/2002	US6500924 Package for using antagonists of the vitronectin receptor alpha-v beta3 comprising a metalloproteinase polypeptide of given amino acid sequence; treating arthritis, rheumatoid arthritis, retinopathy and tumors
12/31/2002	US6500923 Isolated polypeptide that binds to an autoantibody from a dermatomyositis patient to provide means by which dermatomyositis can be detected by way of differential diagnosis
12/31/2002	US6500922 Native polypeptide factors that are capable of association with the intracellular domain of tnf-r2 and participate in the intracellular post-receptor signaling of tnf biological activities
12/31/2002	US6500919 Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma
12/31/2002	US6500674 Method for the diagnosis of brain/neurological disease using monoclonal antibodies specific for PHF-tau, hybridomas secreting them, and antigen recognition by these antibodies and their applications
12/31/2002	US6500672 A competitive assay for binding activity to recombinant hepatocyte nuclear factor-4 receptors, a chimeric receptor comprising the ligand binding domain of a hnf-4 receptor and dna binding domain of another receptor
12/31/2002	US6500670 Changing the oil or biopolymer content of a plant or plant storage organ by introducing an anti-sense or sense construct into a plant resulting in an inactivated pdk gene
12/31/2002	US6500664 Growth differentiation factor-8 family nucleic acid sequences
12/31/2002	US6500662 Infectious cdna clones of positive polarity rna viruses and the construction of vaccines, in particular, swine vaccines, using such cdna clones
12/31/2002	US6500661 Enzymatic synthesis of gdp-fucose, which can be used in fucosylation reactions; the reaction mixture comprising gdp-4-keto-6-deoxymannose, nadph, and a prokaryotic enzyme with epimerase and reductase activity
12/31/2002	US6500660 Chimeric target molecule having an activity which can be regulated or modulated by a binding molecule; methods of using the chimeric target molecule to detect the presence and/or amount of a desired analyte in a sample
12/31/2002	US6500659 A thermostable enzyme that catalyzes the removal of arginine, phenylalanine, or methionine from the n-terminal end of peptides
12/31/2002	US6500657 33167, a novel human hydrolase and uses therefor
12/31/2002	US6500655 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
12/31/2002	US6500654 Cardiac-related ankyrin-repeat protein kinase
12/31/2002	US6500653 Nucleic acids and polypeptides which resemble RHO and which interact with cell signaling pathways and proteins
12/31/2002	US6500652 Use of nucleic acid molecules as antiviral agents
12/31/2002	US6500650 Method for identifying polymorphisms
12/31/2002	US6500648 Methods for recombinant peptide production
12/31/2002	US6500647 Recombinant expression vector which is prepared by inserting a human parathyroid hormone gene containing a urokinase-specific cleavage site into an l-arabinose inducible vector containing a phosphoribulokinase gene fragment of
12/31/2002	US6500646 Drugs in which peptides having affinity specific for phospholipids, preferably those which are contained in the constituents of lipid bilayers forming the surface layers of cells and of which the proportion in the outer part of each
12/31/2002	US6500645 N-terminally extended proteins expressed in yeast
12/31/2002	US6500644 Method for in vivo production of a mutant library in cells
12/31/2002	US6500642 Mammalian cdna which encodes a mammalian mapop-3. it also provides for the use of the cdna, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of breast
12/31/2002	US6500641 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element,
12/31/2002	US6500640 Nucleic acid molecules encoding modified dorsal tissue affecting factor
12/31/2002	US6500639 DNA shuffling to produce nucleic acids for mycotoxin detoxification
12/31/2002	US6500638 Nucleotide sequences for use in the diagnosis and treatment of prostate cancer
12/31/2002	US6500636 Chimeric pre-activated transcription factors
12/31/2002	US6500634 Neurotransmission by excitatory amino acids (eaas) such as glutamate is mediated via membrane-bound surface receptors. dna coding for eaa receptors of one family of human nmda-binding type receptors has now been isolated and receptor
12/31/2002	US6500627 Methods for predicting pregnancy outcome in a subject by HCG assay
12/31/2002	US6500626 Combining in aqueous binding conditions an agent, a bax polypeptide capable of binding to a bcl-2 polypeptide under the aqueous binding conditions, a bcl-2 polypeptide capable of binding to a bax polypeptide under the aqueous binding
12/31/2002	US6500624 Kainate-binding, human CNS receptors of the EAA3 family
12/31/2002	US6500622 Using encoded bead conjugate comprising microsphere semiconductor nanocrystal having fluorescence characteristics and polynucleotide having proximal end and distal end wherein polynucleotide is linked to microsphere at proximal end
12/31/2002	US6500621 Detection uisng mass spectrometry
12/31/2002	US6500620 Methods for amplifying and detecting multiple polynucleotides on a solid phase support
12/31/2002	US6500619 Method for making an improved cloning vector containing marker inactivation system
12/31/2002	US6500617 Recombining plurality of nucleic acids comprising segments derived from a gene that confers resistance to pests such as insects producing a library; expressing encoded polypeptides and assaying
12/31/2002	US6500615 Identifying antisense oligonucleotide binding
12/31/2002	US6500613 Isolated pneumococcal surface protein c, pspc, of strepto-coccus pneumoniae having alpha-helical, proline rich and repeat regions
12/31/2002	US6500435 Vaccine comprising at least three isolated actinobacillus pleuropneumoniae cytolysin proteins having specified amino acid sequences
12/31/2002	US6500433 Polypeptide fragments capable of competition with Streptococcus mutans antigen I/II
12/31/2002	US6500431 Inhibitors of angiogenesis and tumor growth
12/31/2002	US6500428 Antibodies to a lymphocyte surface receptor that binds CAML and methods of use thereof
12/31/2002	US6500426 Carbohydrate-based enzyme-containing granules for use in animal feed
12/31/2002	US6500422 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (LAG-3)
12/31/2002	US6500419 Method for introducing and expressing RNA in animal cells
12/31/2002	US6500211 Hybrid hydrolase enzymes
12/31/2002	CA2249643C Assay for chlamydia trachomatis by amplification and detection of chlamydia trachomatis nucleic acid
12/31/2002	CA2249635C Detection of neisseria gonorrhoeae by amplification and detection of its nucleic acid
12/31/2002	CA2245006C Protein expression system
12/31/2002	CA2244964C Detection of nucleic acids by fluorescence quenching
12/31/2002	CA2201944C Analogs of keratinocyte growth factor having enhanced temperature stability
12/31/2002	CA2157867C High molecular weight surface proteins of non-typeable haemophilus
12/31/2002	CA2096532C New human recombinant gamma-interferon
12/31/2002	CA2069460C Methods and compositions for preparation and use of a herpes protease
12/31/2002	CA2022285C Enhancement of naphthalene dioxygenase activity during microbial indigo production
12/31/2002	CA1341414C Expression vectors of hirudine, transformed cells and process for the preparation of hirudine
12/30/2002	CA2841397A1 Novel compositions and processes for improved analyte detection using hybridization assays
12/30/2002	CA2841389A1 Novel compositions and processes for improved analyte detection using hybridization assays
12/30/2002	CA2714119A1 Novel compositions and processes for improved analyte detection using hybridization assays
12/27/2002	WO2002103363A2 Selection by avidity capture
12/27/2002	WO2002103361A1 Method for identification of agents for the treatment of diabetes
12/27/2002	WO2002103350A1 Methods for cloning mammals using remodeling factors
12/27/2002	WO2002103320A2 Diagnosis and prognosis of breast cancer patients
12/27/2002	WO2002103056A1 Electrophoresis separation media and methods
12/27/2002	WO2002103055A1 METHOD OF DETERMINING A CHEMOTHERAPEUTIC REGIMEN BASED ON GLUTATHIONE-S-TRANSFERASE Pi EXPRESSION
12/27/2002	WO2002103052A1 Amplifiable probe
12/27/2002	WO2002103051A2 Nucleic acid triplex and quadruplex formation
12/27/2002	WO2002103050A2 Virus detection method, primers therefor and screening kit
12/27/2002	WO2002103048A2 Real happy mapping
12/27/2002	WO2002103046A2 Happier mapping
12/27/2002	WO2002103043A2 Method for the specific fast detection of bacteria which is harmful to beer
12/27/2002	WO2002103042A2 Method and nucleic acids for the differentiation of prostate tumors
12/27/2002	WO2002103039A1 A method for measuring dna polymerization and applications of the method
12/27/2002	WO2002103031A2 Methods for detecting and treating the early onset of aging-related conditions
12/27/2002	WO2002103027A1 Glycoprotein and process for producing the same
12/27/2002	WO2002103026A2 Method for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gb41 fragments
12/27/2002	WO2002103024A2 Stabilized proteins with engineered disulfide bonds
12/27/2002	WO2002103022A2 Transgenic cells expressing clucosyltransferases which glucosylate parabenzoic acid
12/27/2002	WO2002103021A2 Method for increasing the carotenoid-content in transgenic plants
12/27/2002	WO2002103020A1 Novel disease-associated gene and use thereof
12/27/2002	WO2002103019A1 Peptides participating in prionization of heterogenous erf3
12/27/2002	WO2002103018A1 Novel polypeptide and use thereof
12/27/2002	WO2002103017A1 Nucleic acids isolated in neuroblastoma
12/27/2002	WO2002103016A2 Human tachykinin-related splice variants and compositions thereof
12/27/2002	WO2002103015A2 Abca10 transporter
12/27/2002	WO2002103014A2 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells
12/27/2002	WO2002103012A1 Chimaeric phages
12/27/2002	WO2002103011A2 Selective gene amplification
12/27/2002	WO2002103010A1 Methods and materials for targeted gene disruption in actinomycete bacteria
12/27/2002	WO2002103009A2 Optimisation of synthetic catalysts by means of directed evolution
12/27/2002	WO2002103008A2 Templated molecules and methods for using such molecules
12/27/2002	WO2002103006A1 Guanosine triphosphate-binding protein-coupled receptors
12/27/2002	WO2002103005A1 Guanosine triphosphate-binding protein-coupled receptors
12/27/2002	WO2002103004A1 Surface modification for improving biocompatibility

1 ... 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 ... 4023